Kolon TissueGene (950160) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Kolon TissueGene (950160) reported revenue of 4 million KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20254 million KRW-16 million KRW-135 million KRW[source]
20244 million KRW-16 million KRW-25 million KRW[source]
20233 million KRW-16 million KRW-13 million KRW[source]
20227 million KRW-13 million KRW-9 million KRW[source]
20213 million KRW-41 million KRW-41 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025295 million KRW251 million KRW45 million KRW[source]
2024151 million KRW52 million KRW99 million KRW[source]
2023105 million KRW15 million KRW89 million KRW[source]
202287 million KRW15 million KRW72 million KRW[source]
202152 million KRW19 million KRW33 million KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice